[1]
|
US Department of Health and Human Services, “Going the Distance: The Ryan White HIV/AIDS Program. 20 Years of Leadership, A Legacy of Care,” 2010.
http://www.impactmc.net/ downloads/samples/writing/ Going-the-Distance-20-years-of-the-Ryan-White- HIV-AIDS-Program.pdf
|
[2]
|
M. Johri, D. A. Paltiel, S. J. Goldie and K. A. Freedberg, “State AIDS Drug Assistance Programs: Equity and Efficiency in an Era of Rapidly Changing Treatment Standards,” Medical Care, Vol. 40, No. 5, 2002, pp. 429-441.
|
[3]
|
D. P. Goldman, J. Bhattacharya, A. A. Leibowitz, G. F. Joyce, M. F. Shapiro and S. A. Bozzette, “The Impact of State Policy on the Costs of HIV Infection,” Medical Care Research and Review, Vol. 58, No. 1, 2001, pp. 31-53.
|
[4]
|
B. R. Schackman, K. A. Gebo, R. P. Walensky, E. Losina, T. Muccio, P. E. Sax, et al., “The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States,” Medical Care, Vol. 44, No. 11, 2006, pp. 990-997. doi:10.1097/01.mlr.0000228021.89490.2a
|
[5]
|
Kaiser Family Foundation, “2009 National ADAP Monitoring Project Annual Report,” The Henry J. Kaiser Family Foundation, 2009.
http://kff.org/hivaids/event/2009-national-adap-monitoring-project-annual-report/
|
[6]
|
R. P. Walensky, A. D. Paltiel and K. A. Freedman. “AIDS Drug Assistance Programs: Highlighting Inequities in Human Immunodeficiency Virus–Infection Health Care in the United States,” Clinical Infectious Diseases, Vol. 35, No. 5, 2002, pp. 606-610. doi:10.1086/341903
|
[7]
|
S. Morin, “Responding to Racial and Ethnic Disparities in Use of HIV Drugs: Analysis of State Policies,” Public Health Reports, Vol. 117, No, 3, 2002, pp. 263-272.
|
[8]
|
A. A. Leibowitz and N. Sood, “Market Power and State Costs of HIV/AIDS Drugs,” International Journal of Health Care Finance and Economics, Vol. 7, No. 1, 2007, pp. 59-71. doi:10.1007/s10754-007-9012-0
|
[9]
|
J. Kahn, “Access to and Use of HIV Antiretroviral Therapy: Variation by Race/ethnicity in Two Public Insurance Programs in the US,” Public Health Reports, Vol. 117, No. 3, 2002, pp. 252-262.
|
[10]
|
B. P. Linas, H. Zheng, E. Losina, A. Rockwell, R. P. Walensky, K. Cranston, et al., “Optimizing Resource Allocation in United States AIDS Drug Assistance Programs,” Clinical Infectious Diseases, Vol. 43, No. 10, 2006, pp. 1357-1364. doi:10.1086/508657
|
[11]
|
J. McCarter, “Obamacare Unpopular, Unless It’s Not Called Obamacare,” Daily Kos, 2012.
|
[12]
|
Pew Research Center, “Health Care Proposals Remain Hard to Follow,” Pew Research Center for the People and the Press, 2009.
http://www.people-press.org/2009/09/08/health-care-proposals-remain-hard-to-follow/
|